Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Biography

Meet the Editorial Board Member

Author(s): Frank Wuest

Volume 23, Issue 4, 2023

Published on: 05 January, 2023

Page: [379 - 379] Pages: 1

DOI: 10.2174/138955752304230105121551

Price: $65

Next »
[1]
O., Tietz; A., Marshall; C., Bergman; M., Wuest; F., Wuest Impact of Structural Alterations on the Radiopharmacological Profile of 18F-labeled Pyrimidines as Cyclooxygenase-2 (COX-2) Imaging Agents. Nucl. Med. Biol., 2018, 62-63, 9-17.
[2]
Hamann, D. Krys, V. Bouvet, D. Glubrecht, A. Marshall, C. Bergman, L. Vos, J. R. Mackey, M. Wuest, F. Wuest. Imaging hypoxia-driven regulation of metabolic markers in breast cancer: Role of GLUT1, GLUT2 and GLUT5. FASEB J., In Press
[3]
B.J., Al-Hourani; B.F., Ali; Z., Judeh; M.I., El-Barghouthi; W., Al-Awaida; Y., Snobar; F., El Soubani; K., Matalqah; F., Wuest Unexpected formation of 1-[4-chloromethylphenyl]-5-[4-(methyl-sulfonyl)benzyl]-1H-tetrazole and 1-[4-chloromethylphenyl]-5-[4-(aminosulfonyl)-phenyl]-1H-tetrazole: Crystal structure, bioassay screening and molecular docking studies. J. Mol. Struct., 2018, 1164, 317-327.
[4]
M., Wagner; M., Wuest; I., Hamann; A., Lopez-Campistrous; T., McMullen; F., Wuest Molecular imaging of platelet-derived growth factor receptor-alpha (PDGFRa) in papillary thyroid cancer using immuno-PET. Nucl. Med. Biol., 2018, 58, 51-58.
[5]
M., Wuest; I., Hamann; V., Bouvet; D., Glubrecht; A., Marshall; B., Trayner; O-M., Soueidan; D., Krys; M., Wagner; C., Cheeseman; F., West; F., Wuest Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer PET Imaging Study in Mice. Mol. Pharmacol., 2018, 93, 79-89.
[6]
S., Berke; A-L., Kampmann; M., Wuest; J.J., Bailey B. Glowacki F. Wuest, K. Jurkschat, R. Weberskirch, R. Schirrmacher. 18F-Radiolabeling and In vivo Analysis of SiFA-derivatized Polymeric Core-Shell Nanoparticles. Bioconjug. Chem., 2018, 29, 89-95.
[7]
T., Kniess; M., Laube; F., Wuest; J., Pietzsch Technetium-99m based Small Molecule Radiopharmaceuticals and Radiotracers Targeting Inflammation and Infection. Dalton Trans., 2017, 46, 14435-14451.
[8]
V., Bouvet; M., Wuest; J., Bailey; C., Bergman; N., Janzen; J.F., Valliant; F., Wuest Targeting prostate-specific membrane antigen (PSMA) with 18F-labeled compounds: The influence of prosthetic groups on tumor uptake and clearance profile. Mol. Imaging Biol., 2017, 19, 923-932.
[9]
G., Meng; X., Tang; Z., Yang; M.M., Benesch; A., Marshall; D., Murray; D.G., Hemmings; F., Wuest; T.P., McMullen; D.N., Brindley Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy. FASEB J., 2017, 31, 4064-4077.
[10]
O-M., Soueidan; T.W., Scully; J., Kaur; R., Panigrahi; A., Belovodskiy; V., Do; C., Matier; J., Lemieux; F., Wuest; C.I., Cheeseman; F.G., West Fluorescent hexose derivatives establish stringent stereochemical requirement by GLUT5 for recognition and transport of monosaccharides. ACS Chem. Biol., 2017, 12, 1087-1094.
[11]
Bhardwaj, J. Kaur, M. Wuest, F. Wuest. In Situ Click Chemistry Generation of Cyclooxygenase-2 Inhibitors. Nature Commun., 2017, 8, 1.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy